Clinical trial for Chronic Obstructive Pulmonary Disease
Official title PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
ClinicalTrials.gov ID: NCT05306743
What this study is testing
- What it's testing
- The study aims to see whether a quality‑improvement and clinical decision‑support package improves outcomes for people with modifiable high‑risk chronic obstructive pulmonary disease.
- Who it's for
- Adults who have high‑risk COPD, whether or not they have a current diagnosis.
- What's involved
- Clinics will be randomly assigned to use the quality‑improvement program (including decision‑support tools) or to continue usual care. Participants will follow the care plan used by their clinic and may have routine check‑ups and tests as part of the study.
- Time commitment
- The trial runs for about three years, with regular clinic visits as determined by the participating health center.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- As a cluster assigned by chance controlled trial, participants in PREVAIL are the Primary Care Teams.
- Primary Care Teams (PCTs) must be able to function as a single randomization unit with low risk of contamination between participants and physicians...
- PCT must have a sufficient number of patients meeting modifiable high-risk patient criteria (see section 8.1 on sample size estimates).
- PCT must express willingness to be assigned by chance to either receive the CONQUEST program initially, or usual care until program roll-out to the...
You likely can't join if
- PCTs that are in the process of, or planning to change EHR software provider or practice ownership within the trial outcome evaluation period
- PCTs engaged in active research studies or COPD related Quality Improvement Programs which might impact the ability to implement CONQUEST program.
The study team makes the final eligibility decision.
Where it is enrolling
- Denver, Colorado, United States
- New York, New York, United States
- Cleveland, Ohio, United States
Compensation & support
A stipend or payment for your time may be offered.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Denver, Colorado, United States; New York, New York, United States; Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.